Yoo, W.; Lee, J.; Jun, E.; Noh, K.H.; Lee, S.; Jung, D.; Jung, K.H.; Kim, J.-S.; Park, Y.-Y.; Kim, S.C.;
et al. The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target. Cancers 2019, 11, 1477.
https://doi.org/10.3390/cancers11101477
AMA Style
Yoo W, Lee J, Jun E, Noh KH, Lee S, Jung D, Jung KH, Kim J-S, Park Y-Y, Kim SC,
et al. The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target. Cancers. 2019; 11(10):1477.
https://doi.org/10.3390/cancers11101477
Chicago/Turabian Style
Yoo, Wonbeak, Jaemin Lee, Eunsung Jun, Kyung Hee Noh, Sangmin Lee, Dana Jung, Kwang Hwa Jung, Ji-Su Kim, Yun-Yong Park, Song Cheol Kim,
and et al. 2019. "The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target" Cancers 11, no. 10: 1477.
https://doi.org/10.3390/cancers11101477
APA Style
Yoo, W., Lee, J., Jun, E., Noh, K. H., Lee, S., Jung, D., Jung, K. H., Kim, J. -S., Park, Y. -Y., Kim, S. C., & Kim, S.
(2019). The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target. Cancers, 11(10), 1477.
https://doi.org/10.3390/cancers11101477